Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ernesto Aycardi
Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study
Journal of the Neurological Sciences
Neurology
Related publications
Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy
Multiple Sclerosis
Neurology
Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study
BMC Neurology
Medicine
Neurology
Network Analysis of Transcriptional Regulation in Response to Intramuscular Interferon-Β-1a Multiple Sclerosis Treatment
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Changes in Magnetic Resonance Imaging Disease Measures Over 3 Years in Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) Study
BMC Neurology
Medicine
Neurology
Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Clinical Features, Diagnosis and Therapeutic Strategies in Pediatric Multiple Sclerosis
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Seasonal Adherence To, and Effectiveness Of, Subcutaneous Interferon Β-1a Administered by RebiSmart® in Patients With Relapsing Multiple Sclerosis: Results of the 1-Year, Observational GEPAT-SMART Study
BMC Neurology
Medicine
Neurology
Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study
BMC Neurology
Medicine
Neurology